Niacin simvastatin

Results: 24



#Item
1niaspan
[removed]niaspan

niaspan [removed]niaspan

Add to Reading List

Source URL: www.rxabbvie.com

Language: English - Date: 2014-08-11 06:56:59
2Niacin ER/Simvastatin (ABT-118) M10-013 Clinical Study Report - SUPREME R&D[removed]

Niacin ER/Simvastatin (ABT-118) M10-013 Clinical Study Report - SUPREME R&D[removed]

Add to Reading List

Source URL: www.abbvie.com

Language: English - Date: 2014-10-07 02:44:39
3March 2012 Michael Cobble, MD Chief Medical Officer Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. Christie Ballantyne, MD, et al. J

March 2012 Michael Cobble, MD Chief Medical Officer Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. Christie Ballantyne, MD, et al. J

Add to Reading List

Source URL: www.atherotech.com

Language: English - Date: 2012-03-22 16:47:40
4Microsoft Word - DUR Committee Oct Agenda2.doc

Microsoft Word - DUR Committee Oct Agenda2.doc

Add to Reading List

Source URL: www.mainecarepdl.org

Language: English - Date: 2014-10-08 09:02:37
5Microsoft PowerPoint - FINAL_Merck_Strung.ppt

Microsoft PowerPoint - FINAL_Merck_Strung.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
6©  April - May 2014 Serious Adverse Events

© April - May 2014 Serious Adverse Events

Add to Reading List

Source URL: www.ti.ubc.ca

Language: English - Date: 2014-05-28 18:46:02
7Trilipix® (fenofibric acid) Delayed Release Capsules EMDAC Meeting - Sponsor Briefing Document 19 April 2011 Advisory Committee Briefing Document

Trilipix® (fenofibric acid) Delayed Release Capsules EMDAC Meeting - Sponsor Briefing Document 19 April 2011 Advisory Committee Briefing Document

Add to Reading List

Source URL: www.fda.gov

Language: English
8Microsoft PowerPoint - Abbott - Trilipix AdCom[removed]Presentation and Supporting Backups

Microsoft PowerPoint - Abbott - Trilipix AdCom[removed]Presentation and Supporting Backups

Add to Reading List

Source URL: www.fda.gov

Language: English
9DN1628V4_simcor_021408 ————— CONTRAINDICATIONS ————— HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Simcor safely and effectively. See full pre

DN1628V4_simcor_021408 ————— CONTRAINDICATIONS ————— HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Simcor safely and effectively. See full pre

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:10:59
10PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING

PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE MEETING

Add to Reading List

Source URL: chfs.ky.gov

Language: English - Date: 2014-11-28 11:18:52